Fundamentals of Market Access for Pharmaceuticals

Rezensionen / Stimmen

"Based on the concept of drug whole life cycle, the authors have established a framework of value assessment, pricing and reimbursement for pharmaceuticals and illustrates how different health systems are facing a variety of challenges and opportunities. The book addresses, governmental and market forces impacting on market access from a global perspective taking into account politics, regulations, culture, ethics, and values. The content of this book has been shaped by three years of teach-ing practice in CEIBS and has been well received. Another feature is a large number of cases in each chapter from the United States, the European Union, and China." - Shanlian Hu. MD, MSc. Professor of Health Economics, School of Public Health, Fudan University "If health is indeed a 'supreme good' that every human being deserves, achieving it involves navigating a complex web of factors, including scientific advancement, public policy, economic limitations, and organization development. These factors vary widely across different regions and over time. The role of pharmaceuticals in promoting health is pivotal. Therefore, the study of pharmaceutical market ac-cess must extend beyond the context of developed nations to include the unique challenges and op-portunities in emerging and developing countries. This book by Eric Boutellier and Annie Chicoye is a timely and valuable resource that will significantly benefit students and professionals in the field." - Gerard Viens, Emeritus Professor, Health Economics, ESSEC Graduate School I highly recommend this book for not only providing the economic fundamentals but also explaining the complexities and challenges in improving real-world access for patients -Prof Lou Garisson, Washington University